_id
691719d53c536f8df2316559
Ticker
SUVZ
Name
Suvanza Pharma LLC
Exchange
OTCCE
Address
5401 Collins Avenue, Miami Beach, FL, United States, 33140
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.suvanza.com
Description
Suvanza Pharma, LLC operates as an early-stage biotechnology corporation and engages in the development of the skin drug delivery system, RapiDerm for dermatologic diseases. Suvanza Pharma, LLC was formerly known as Hamilton PNG and changed its name to Suvanza Pharma, LLC in March 2010. The company was founded in 2004 and is based in Miami Beach, Florida.
Last Close
0.0002
Volume
-
Current Price
0.0002
Change
0
Last Updated
2026-01-07T12:38:05.149Z
Image
-
Ipo Date
-
Market Cap
1007720
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2003-03-31
Revenue
7000
Cost Of Revenue
224000
Gross Profit
-217000
Operating Expenses
0
Operating Income
-2673000
Interest Expense
2000
Pretax Income
-2671000
Net Income
-2671000
Eps
-
Dividends Per Share
-
Shares Outstanding
0
Income Tax Expense
0
EBITDA
-
Operating Margin
-38185.71428571428
Total Other Income Expense Net
4000
Cash
609000
Short Term Investments
-
Receivables
-
Inventories
-
Total Current Assets
1747000
Property Plant Equipment
1515000
Total Assets
6208000
Payables
1949000
Short Term Debt
24000
Long Term Debt
43000
Total Liabilities
2016000
Equity
4192000
Bs_currency_symbol
USD
Depreciation
921000
Change In Working Capital
-
Cash From Operations
-1967000
Capital Expenditures
5000
Cash From Investing
-5000
Cash From Financing
-6000
Net Change In Cash
-1978000
Cf_currency_symbol
USD
PE
-
PB
-
ROE
-63.716603053435115
ROA
-43.02512886597938
FCF
-1972000
Fcf Percent
-281.7142857142857
Piotroski FScore
1
Health Score
36
Deep Value Investing Score
4
Defensive Investing Score
5.5
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
2
Growth Investing Score
0.5
Momentum Investing Score
2
Net Net Investing Score
2
Quality Investing Score
2.5
Value Investing Score
2.5
Quarters > 0 > quarter
2003-03-31
Quarters > 0 > income Statement > revenue
7000
Quarters > 0 > income Statement > cost Of Revenue
224000
Quarters > 0 > income Statement > gross Profit
-217000
Quarters > 0 > income Statement > operating Expenses
0
Quarters > 0 > income Statement > operating Income
-2673000
Quarters > 0 > income Statement > interest Expense
2000
Quarters > 0 > income Statement > pretax Income
-2671000
Quarters > 0 > income Statement > net Income
-2671000
Quarters > 0 > income Statement > eps
-
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
-
Quarters > 0 > income Statement > income Tax Expense
0
Quarters > 0 > income Statement > EBITDA
-
Quarters > 0 > income Statement > operating Margin
-38185.71428571428
Quarters > 0 > income Statement > total Other Income Expense Net
4000
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
609000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
1747000
Quarters > 0 > balance Sheet > property Plant Equipment
1515000
Quarters > 0 > balance Sheet > total Assets
6208000
Quarters > 0 > balance Sheet > payables
1949000
Quarters > 0 > balance Sheet > short Term Debt
24000
Quarters > 0 > balance Sheet > long Term Debt
43000
Quarters > 0 > balance Sheet > total Liabilities
2016000
Quarters > 0 > balance Sheet > equity
4192000
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-2671000
Quarters > 0 > cash Flow > depreciation
921000
Quarters > 0 > cash Flow > change In Working Capital
-
Quarters > 0 > cash Flow > cash From Operations
-1967000
Quarters > 0 > cash Flow > capital Expenditures
5000
Quarters > 0 > cash Flow > cash From Investing
-5000
Quarters > 0 > cash Flow > cash From Financing
-6000
Quarters > 0 > cash Flow > net Change In Cash
-1978000
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-
Quarters > 0 > ratios > PB
-
Quarters > 0 > ratios > ROE
-63.716603053435115
Quarters > 0 > ratios > ROA
-43.02512886597938
Quarters > 0 > ratios > FCF
-1972000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-281.7142857142857
Quarters > 0 > health Score
36
Quarters > 1 > quarter
2002-12-31
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
194000
Quarters > 1 > income Statement > gross Profit
-194000
Quarters > 1 > income Statement > operating Expenses
0
Quarters > 1 > income Statement > operating Income
-3723000
Quarters > 1 > income Statement > interest Expense
1000
Quarters > 1 > income Statement > pretax Income
-3710000
Quarters > 1 > income Statement > net Income
-3546000
Quarters > 1 > income Statement > eps
-
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
-
Quarters > 1 > income Statement > income Tax Expense
-164000
Quarters > 1 > income Statement > EBITDA
-
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
14000
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
2587000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
164000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
3328000
Quarters > 1 > balance Sheet > property Plant Equipment
1945000
Quarters > 1 > balance Sheet > total Assets
8727000
Quarters > 1 > balance Sheet > payables
1791000
Quarters > 1 > balance Sheet > short Term Debt
24000
Quarters > 1 > balance Sheet > long Term Debt
49000
Quarters > 1 > balance Sheet > total Liabilities
1864000
Quarters > 1 > balance Sheet > equity
6863000
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-3546000
Quarters > 1 > cash Flow > depreciation
1077000
Quarters > 1 > cash Flow > change In Working Capital
-
Quarters > 1 > cash Flow > cash From Operations
-2321000
Quarters > 1 > cash Flow > capital Expenditures
398000
Quarters > 1 > cash Flow > cash From Investing
-4000
Quarters > 1 > cash Flow > cash From Financing
1000
Quarters > 1 > cash Flow > net Change In Cash
-2324000
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-
Quarters > 1 > ratios > PB
-
Quarters > 1 > ratios > ROE
-51.66836660352615
Quarters > 1 > ratios > ROA
-40.632519766242694
Quarters > 1 > ratios > FCF
-2719000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
44
Quarters > 2 > quarter
2002-09-30
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
962000
Quarters > 2 > income Statement > gross Profit
-962000
Quarters > 2 > income Statement > operating Expenses
0
Quarters > 2 > income Statement > operating Income
-3573000
Quarters > 2 > income Statement > interest Expense
1000
Quarters > 2 > income Statement > pretax Income
-3560000
Quarters > 2 > income Statement > net Income
-3560000
Quarters > 2 > income Statement > eps
-
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
-
Quarters > 2 > income Statement > income Tax Expense
0
Quarters > 2 > income Statement > EBITDA
-
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
13000
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
4846000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
5193000
Quarters > 2 > balance Sheet > property Plant Equipment
2303000
Quarters > 2 > balance Sheet > total Assets
12081000
Quarters > 2 > balance Sheet > payables
1677000
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
1677000
Quarters > 2 > balance Sheet > equity
10404000
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-3560000
Quarters > 2 > cash Flow > depreciation
1057000
Quarters > 2 > cash Flow > change In Working Capital
-
Quarters > 2 > cash Flow > cash From Operations
-3174000
Quarters > 2 > cash Flow > capital Expenditures
467000
Quarters > 2 > cash Flow > cash From Investing
-467000
Quarters > 2 > cash Flow > cash From Financing
5000000
Quarters > 2 > cash Flow > net Change In Cash
1359000
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-
Quarters > 2 > ratios > PB
-
Quarters > 2 > ratios > ROE
-34.21760861207228
Quarters > 2 > ratios > ROA
-29.467759291449386
Quarters > 2 > ratios > FCF
-3641000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
44
Quarters > 3 > quarter
2002-06-30
Quarters > 3 > income Statement > revenue
0
Quarters > 3 > income Statement > cost Of Revenue
0
Quarters > 3 > income Statement > gross Profit
0
Quarters > 3 > income Statement > operating Expenses
0
Quarters > 3 > income Statement > operating Income
-5653000
Quarters > 3 > income Statement > interest Expense
1000
Quarters > 3 > income Statement > pretax Income
-5633000
Quarters > 3 > income Statement > net Income
-5633000
Quarters > 3 > income Statement > eps
-
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
-
Quarters > 3 > income Statement > income Tax Expense
0
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
21000
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
3549000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
3737000
Quarters > 3 > balance Sheet > property Plant Equipment
2250000
Quarters > 3 > balance Sheet > total Assets
11215000
Quarters > 3 > balance Sheet > payables
2251000
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
2251000
Quarters > 3 > balance Sheet > equity
8964000
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-5633000
Quarters > 3 > cash Flow > depreciation
992000
Quarters > 3 > cash Flow > change In Working Capital
-
Quarters > 3 > cash Flow > cash From Operations
-3430000
Quarters > 3 > cash Flow > capital Expenditures
240000
Quarters > 3 > cash Flow > cash From Investing
-240000
Quarters > 3 > cash Flow > cash From Financing
1982000
Quarters > 3 > cash Flow > net Change In Cash
-1688000
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-
Quarters > 3 > ratios > PB
-
Quarters > 3 > ratios > ROE
-62.840249888442656
Quarters > 3 > ratios > ROA
-50.22737405260811
Quarters > 3 > ratios > FCF
-3670000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
44
Annuals > 0 > quarter
2002-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
1156000
Annuals > 0 > income Statement > gross Profit
-1156000
Annuals > 0 > income Statement > operating Expenses
0
Annuals > 0 > income Statement > operating Income
-17066000
Annuals > 0 > income Statement > interest Expense
0
Annuals > 0 > income Statement > pretax Income
-16999000
Annuals > 0 > income Statement > net Income
-16835000
Annuals > 0 > income Statement > eps
-
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
-
Annuals > 0 > income Statement > income Tax Expense
-164000
Annuals > 0 > income Statement > EBITDA
-
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
76000
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
2587000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
164000
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
3328000
Annuals > 0 > balance Sheet > property Plant Equipment
1945000
Annuals > 0 > balance Sheet > total Assets
8727000
Annuals > 0 > balance Sheet > payables
1791000
Annuals > 0 > balance Sheet > short Term Debt
24000
Annuals > 0 > balance Sheet > long Term Debt
49000
Annuals > 0 > balance Sheet > total Liabilities
1864000
Annuals > 0 > balance Sheet > equity
6863000
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-16835000
Annuals > 0 > cash Flow > depreciation
3907000
Annuals > 0 > cash Flow > change In Working Capital
-
Annuals > 0 > cash Flow > cash From Operations
-12398000
Annuals > 0 > cash Flow > capital Expenditures
349000
Annuals > 0 > cash Flow > cash From Investing
-1251000
Annuals > 0 > cash Flow > cash From Financing
10797000
Annuals > 0 > cash Flow > net Change In Cash
-2852000
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-
Annuals > 0 > ratios > PB
-
Annuals > 0 > ratios > ROE
-245.3008888241294
Annuals > 0 > ratios > ROA
-192.90707001260458
Annuals > 0 > ratios > FCF
-12747000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
35
Annuals > 1 > quarter
2001-12-31
Annuals > 1 > income Statement > revenue
51000
Annuals > 1 > income Statement > cost Of Revenue
0
Annuals > 1 > income Statement > gross Profit
51000
Annuals > 1 > income Statement > operating Expenses
0
Annuals > 1 > income Statement > operating Income
-21873000
Annuals > 1 > income Statement > interest Expense
0
Annuals > 1 > income Statement > pretax Income
-21536000
Annuals > 1 > income Statement > net Income
-20862000
Annuals > 1 > income Statement > eps
-
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
-
Annuals > 1 > income Statement > income Tax Expense
0
Annuals > 1 > income Statement > EBITDA
-
Annuals > 1 > income Statement > operating Margin
-42888.23529411764
Annuals > 1 > income Statement > total Other Income Expense Net
399000
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
5838000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
5994000
Annuals > 1 > balance Sheet > property Plant Equipment
2677000
Annuals > 1 > balance Sheet > total Assets
11308000
Annuals > 1 > balance Sheet > payables
1154000
Annuals > 1 > balance Sheet > short Term Debt
225000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
1379000
Annuals > 1 > balance Sheet > equity
9929000
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-20862000
Annuals > 1 > cash Flow > depreciation
3852000
Annuals > 1 > cash Flow > change In Working Capital
-
Annuals > 1 > cash Flow > cash From Operations
-12942000
Annuals > 1 > cash Flow > capital Expenditures
865000
Annuals > 1 > cash Flow > cash From Investing
-865000
Annuals > 1 > cash Flow > cash From Financing
11382000
Annuals > 1 > cash Flow > net Change In Cash
-2425000
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-
Annuals > 1 > ratios > PB
-
Annuals > 1 > ratios > ROE
-210.1117937355222
Annuals > 1 > ratios > ROA
-184.4888574460559
Annuals > 1 > ratios > FCF
-13807000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-270.72549019607845
Annuals > 1 > health Score
35
Annuals > 2 > quarter
2000-12-31
Annuals > 2 > income Statement > revenue
1000
Annuals > 2 > income Statement > cost Of Revenue
0
Annuals > 2 > income Statement > gross Profit
1000
Annuals > 2 > income Statement > operating Expenses
0
Annuals > 2 > income Statement > operating Income
-10363000
Annuals > 2 > income Statement > interest Expense
0
Annuals > 2 > income Statement > pretax Income
-9468000
Annuals > 2 > income Statement > net Income
-9468000
Annuals > 2 > income Statement > eps
-
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
-
Annuals > 2 > income Statement > income Tax Expense
0
Annuals > 2 > income Statement > EBITDA
-
Annuals > 2 > income Statement > operating Margin
-1036300
Annuals > 2 > income Statement > total Other Income Expense Net
895000
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
10121000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
10163000
Annuals > 2 > balance Sheet > property Plant Equipment
2409000
Annuals > 2 > balance Sheet > total Assets
20855000
Annuals > 2 > balance Sheet > payables
3165000
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
3165000
Annuals > 2 > balance Sheet > equity
17690000
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-9468000
Annuals > 2 > cash Flow > depreciation
445000
Annuals > 2 > cash Flow > change In Working Capital
-
Annuals > 2 > cash Flow > cash From Operations
-7926000
Annuals > 2 > cash Flow > capital Expenditures
2467000
Annuals > 2 > cash Flow > cash From Investing
-7238000
Annuals > 2 > cash Flow > cash From Financing
6398000
Annuals > 2 > cash Flow > net Change In Cash
-8766000
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-
Annuals > 2 > ratios > PB
-
Annuals > 2 > ratios > ROE
-53.52176370830978
Annuals > 2 > ratios > ROA
-45.399184847758335
Annuals > 2 > ratios > FCF
-10393000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-10393
Annuals > 2 > health Score
35
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
-63.716603053435115
Profitability > metrics > ROA
-152.89066971951917
Profitability > metrics > Net Margin
-381.57142857142856
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.48091603053435117
Risk > metrics > Interest Coverage
-1336.5
Risk > final Score
-5286
Risk > verdict
High
Liquidity > metrics > Current Ratio
0.88545362392296
Liquidity > metrics > Quick Ratio
0.88545362392296
Liquidity > final Score
54
Liquidity > verdict
Weak
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
50
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
15
Prev Risks > 0
-14832
Prev Risks > 1
-14232
Prev Risks > 2
-22552
Prev Liquidities > 0
96
Prev Liquidities > 1
100
Prev Liquidities > 2
92
Updated At
2026-01-20T22:39:08.172Z
Suvanza Pharma, LLC operates as an early-stage biotechnology corporation and engages in the development of the skin drug delivery system, RapiDerm for dermatologic diseases. Suvanza Pharma, LLC was formerly known as Hamilton PNG and changed its name to Suvanza Pharma, LLC in March 2010. The company was founded in 2004 and is based in Miami Beach, Florida.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AXpeng offers up to $5,000 cashback on G6 electric SUV to clear 2025 stock The Driven
Read more →Showing 2 of 10
(Last Updated 2003-03-31)
Health Score
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Suvanza Pharma LLC
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
No earnings data available.
(Last Updated 2003-03-31)
(Last Updated 2003-03-31)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2003-03-31)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2003-03-31)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.